This invention relates to a series of substitituted amino acids of Formula I
1
pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention are small molecules which bind to the erythropoietin receptor and compete with the natural ligand for binding to this receptor.
本发明涉及一系列式 I 的取代
氨基酸
1
含有它们的药物组合物以及用于制造它们的中间体。本发明的化合物是与促红细胞生成素受体结合并与天然
配体竞争结合的小分子。